These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effect of fusidic acid on interleukin-1 (IL-1)- and IL-6-induced pancreatic beta-cell functions in rats. Bendtzen K; Diamant M; Horn T; Pedersen C; Buschard K J Endocrinol; 1992 Mar; 132(3):345-52. PubMed ID: 1564418 [TBL] [Abstract][Full Text] [Related]
3. Antidiabetogenic effect of fusidic acid in diabetes prone BB rats: a sex-dependent organ accumulation of the drug is seen. Hageman I; Buschard K Pharmacol Toxicol; 2002 Sep; 91(3):123-8. PubMed ID: 12427112 [TBL] [Abstract][Full Text] [Related]
4. Reduction of spontaneous autoimmune diabetes in diabetes-prone BB rats with the novel immunosuppressant fusidic acid. Effect on T-cell proliferation and production of interferon-gamma. Nicoletti F; Di Marco R; Morrone S; Zaccone P; Lembo D; Grasso S; Santoni A; Meroni PL; Bendtzen K Immunology; 1994 Feb; 81(2):317-21. PubMed ID: 8157281 [TBL] [Abstract][Full Text] [Related]
5. Cytokine gene expression in islets and thyroids of BB rats. IFN-gamma and IL-12p40 mRNA increase with age in both diabetic and insulin-treated nondiabetic BB rats. Zipris D; Greiner DL; Malkani S; Whalen B; Mordes JP; Rossini AA J Immunol; 1996 Feb; 156(3):1315-21. PubMed ID: 8558012 [TBL] [Abstract][Full Text] [Related]
6. Morphological effects of sodium fusidate (fusidin) on pancreatic islet cells: an electron microscopic study. Horn T; Bendtzen K; Hageman I; Buschard K Pharmacol Toxicol; 1994; 75(3-4):228-30. PubMed ID: 7800668 [TBL] [Abstract][Full Text] [Related]
8. Prevention of diabetes and induction of non-specific suppressor cell activity in the BB rat by an immunomodulatory azaspirane, SK&F 106610. Rabinovitch A; Suarez WL; Qin HY; Power RF; Badger AM J Autoimmun; 1993 Feb; 6(1):39-49. PubMed ID: 8457285 [TBL] [Abstract][Full Text] [Related]
9. Insulitis and mechanisms of disease resistance: studies in an animal model of insulin dependent diabetes mellitus. Bone AJ; Hitchcock PR; Gwilliam DJ; Cunningham JM; Barley J J Mol Med (Berl); 1999 Jan; 77(1):57-61. PubMed ID: 9930928 [TBL] [Abstract][Full Text] [Related]
10. Effects of sodium fusidate in animal models of insulin-dependent diabetes mellitus and septic shock. Nicoletti F; Zaccone P; Di Marco R; Magro G; Grasso S; Morrone S; Santoni A; Tempera G; Meroni PL; Bendtzen K Immunology; 1995 Aug; 85(4):645-50. PubMed ID: 7558161 [TBL] [Abstract][Full Text] [Related]
11. Protection from BB rat diabetes by the platelet-activating factor inhibitor BN50730. Jobe LW; Ubungen R; Goodner CJ; Baskin DG; Braquet P; Lernmark A Autoimmunity; 1993; 16(4):259-66. PubMed ID: 8025205 [TBL] [Abstract][Full Text] [Related]
12. Effects of a protective hydrolyzed casein diet upon the metabolic and secretory responses of pancreatic islets to IL-1beta, cytokine production by mesenteric lymph node cells, mitogenic and biosynthetic activities in Peyer's patch cells, and mitogenic activity in pancreatic lymph node cells from control and diabetes-prone BB rats. Olivares E; Ladrière L; Laghmich A; Sener A; Malaisse WJ; Scott FW Mol Genet Metab; 1999 Nov; 68(3):379-90. PubMed ID: 10562466 [TBL] [Abstract][Full Text] [Related]
13. Glimepiride-induced prevention of diabetes and autoimmune events in the BB rat: revised. Cheta DM; Lim J; Chan EK; Kunakorn T; Charles MA Life Sci; 1995; 57(24):2281-90. PubMed ID: 7475982 [TBL] [Abstract][Full Text] [Related]
14. Prevention of diabetes in the BB rat by early immunotherapy using Freund's adjuvant. Sadelain MW; Qin HY; Sumoski W; Parfrey N; Singh B; Rabinovitch A J Autoimmun; 1990 Dec; 3(6):671-80. PubMed ID: 2088390 [TBL] [Abstract][Full Text] [Related]
15. Genetically determined differences in newborn rat islet sensitivity to interleukin-1 in vitro: no association with the diabetes prone phenotype in the BB-rat. Andersen HU; Mandrup-Poulsen T; Egeberg J; Helqvist S; Nerup J Acta Endocrinol (Copenh); 1989 Jan; 120(1):92-8. PubMed ID: 2643251 [TBL] [Abstract][Full Text] [Related]
16. Antioxidant enzyme activity and mRNA expression in the islets of Langerhans from the BB/S rat model of type 1 diabetes and an insulin-producing cell line. Sigfrid LA; Cunningham JM; Beeharry N; Håkan Borg LA; Rosales Hernandez AL; Carlsson C; Bone AJ; Green IC J Mol Med (Berl); 2004 May; 82(5):325-35. PubMed ID: 15007513 [TBL] [Abstract][Full Text] [Related]
17. Long-term prophylactic insulin treatment can prevent spontaneous diabetes and thyroiditis development in the diabetes-prone bio-breeding rat, while short-term treatment is ineffective. Visser J; Klatter F; Vis L; Groen H; Strubbe J; Rozing J Eur J Endocrinol; 2003 Sep; 149(3):223-9. PubMed ID: 12943525 [TBL] [Abstract][Full Text] [Related]
18. Prevention of diabetes in BB/Wor rats by intrathymic islet injection. Koevary SB; Blomberg M J Clin Invest; 1992 Feb; 89(2):512-6. PubMed ID: 1737841 [TBL] [Abstract][Full Text] [Related]
19. Interleukin-1 beta (IL-1) does not reduce the diabetes incidence in diabetes-prone BB rats. Reimers JI; Mørch L; Markholst H; Wogensen LD; Andersen HU; Mandrup-Poulsen T; Nerup J Autoimmunity; 1994; 17(2):105-18. PubMed ID: 8061161 [TBL] [Abstract][Full Text] [Related]
20. Treatment with streptococcal preparation (OK-432) suppresses anti-islet autoimmunity and prevents diabetes in BB rats. Satoh J; Shintani S; Oya K; Tanaka S; Nobunaga T; Toyota T; Goto Y Diabetes; 1988 Sep; 37(9):1188-94. PubMed ID: 3044884 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]